Global Personalized Medicine Market Size, Status and Forecast 2024-2031

Report ID: 918191 | Published Date: Jan 2025 | No. of Page: 117 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Personalized Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Personalized Medicine Diagnostics
        1.2.3 Personalized Medical Care
        1.2.4 Personalized Medicine Therapeutics
        1.2.5 Personalized Nutrition and Wellness
    1.3 Market by Application
        1.3.1 Global Personalized Medicine Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Oncology
        1.3.3 Central Nervous System (CNS)
        1.3.4 Immunology
        1.3.5 Respiratory
        1.3.6 Other Applications
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Personalized Medicine Market Perspective (2016-2027)
    2.2 Personalized Medicine Growth Trends by Regions
        2.2.1 Personalized Medicine Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Personalized Medicine Historic Market Share by Regions (2016-2021)
        2.2.3 Personalized Medicine Forecasted Market Size by Regions (2022-2027)
    2.3 Personalized Medicine Industry Dynamic
        2.3.1 Personalized Medicine Market Trends
        2.3.2 Personalized Medicine Market Drivers
        2.3.3 Personalized Medicine Market Challenges
        2.3.4 Personalized Medicine Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Personalized Medicine Players by Revenue
        3.1.1 Global Top Personalized Medicine Players by Revenue (2016-2021)
        3.1.2 Global Personalized Medicine Revenue Market Share by Players (2016-2021)
    3.2 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Personalized Medicine Revenue
    3.4 Global Personalized Medicine Market Concentration Ratio
        3.4.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2020
    3.5 Personalized Medicine Key Players Head office and Area Served
    3.6 Key Players Personalized Medicine Product Solution and Service
    3.7 Date of Enter into Personalized Medicine Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Medicine Breakdown Data by Type
    4.1 Global Personalized Medicine Historic Market Size by Type (2016-2021)
    4.2 Global Personalized Medicine Forecasted Market Size by Type (2022-2027)

5 Personalized Medicine Breakdown Data by Application
    5.1 Global Personalized Medicine Historic Market Size by Application (2016-2021)
    5.2 Global Personalized Medicine Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Personalized Medicine Market Size (2016-2027)
    6.2 North America Personalized Medicine Market Size by Type
        6.2.1 North America Personalized Medicine Market Size by Type (2016-2021)
        6.2.2 North America Personalized Medicine Market Size by Type (2022-2027)
        6.2.3 North America Personalized Medicine Market Size by Type (2016-2027)
    6.3 North America Personalized Medicine Market Size by Application
        6.3.1 North America Personalized Medicine Market Size by Application (2016-2021)
        6.3.2 North America Personalized Medicine Market Size by Application (2022-2027)
        6.3.3 North America Personalized Medicine Market Size by Application (2016-2027)
    6.4 North America Personalized Medicine Market Size by Country
        6.4.1 North America Personalized Medicine Market Size by Country (2016-2021)
        6.4.2 North America Personalized Medicine Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Personalized Medicine Market Size (2016-2027)
    7.2 Europe Personalized Medicine Market Size by Type
        7.2.1 Europe Personalized Medicine Market Size by Type (2016-2021)
        7.2.2 Europe Personalized Medicine Market Size by Type (2022-2027)
        7.2.3 Europe Personalized Medicine Market Size by Type (2016-2027)
    7.3 Europe Personalized Medicine Market Size by Application
        7.3.1 Europe Personalized Medicine Market Size by Application (2016-2021)
        7.3.2 Europe Personalized Medicine Market Size by Application (2022-2027)
        7.3.3 Europe Personalized Medicine Market Size by Application (2016-2027)
    7.4 Europe Personalized Medicine Market Size by Country
        7.4.1 Europe Personalized Medicine Market Size by Country (2016-2021)
        7.4.2 Europe Personalized Medicine Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Personalized Medicine Market Size (2016-2027)
    8.2 Asia-Pacific Personalized Medicine Market Size by Type
        8.2.1 Asia-Pacific Personalized Medicine Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Personalized Medicine Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Personalized Medicine Market Size by Type (2016-2027)
    8.3 Asia-Pacific Personalized Medicine Market Size by Application
        8.3.1 Asia-Pacific Personalized Medicine Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Personalized Medicine Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Personalized Medicine Market Size by Application (2016-2027)
    8.4 Asia-Pacific Personalized Medicine Market Size by Region
        8.4.1 Asia-Pacific Personalized Medicine Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Personalized Medicine Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Personalized Medicine Market Size (2016-2027)
    9.2 Latin America Personalized Medicine Market Size by Type
        9.2.1 Latin America Personalized Medicine Market Size by Type (2016-2021)
        9.2.2 Latin America Personalized Medicine Market Size by Type (2022-2027)
        9.2.3 Latin America Personalized Medicine Market Size by Type (2016-2027)
    9.3 Latin America Personalized Medicine Market Size by Application
        9.3.1 Latin America Personalized Medicine Market Size by Application (2016-2021)
        9.3.2 Latin America Personalized Medicine Market Size by Application (2022-2027)
        9.3.3 Latin America Personalized Medicine Market Size by Application (2016-2027)
    9.4 Latin America Personalized Medicine Market Size by Country
        9.4.1 Latin America Personalized Medicine Market Size by Country (2016-2021)
        9.4.2 Latin America Personalized Medicine Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Personalized Medicine Market Size (2016-2027)
    10.2 Middle East & Africa Personalized Medicine Market Size by Type
        10.2.1 Middle East & Africa Personalized Medicine Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Personalized Medicine Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Personalized Medicine Market Size by Type (2016-2027)
    10.3 Middle East & Africa Personalized Medicine Market Size by Application
        10.3.1 Middle East & Africa Personalized Medicine Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Personalized Medicine Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Personalized Medicine Market Size by Application (2016-2027)
    10.4 Middle East & Africa Personalized Medicine Market Size by Country
        10.4.1 Middle East & Africa Personalized Medicine Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Personalized Medicine Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Personalized Medicine Introduction
        11.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2016-2021)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Agilent Technologies
        11.2.1 Agilent Technologies Company Details
        11.2.2 Agilent Technologies Business Overview
        11.2.3 Agilent Technologies Personalized Medicine Introduction
        11.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2016-2021)
        11.2.5 Agilent Technologies Recent Development
    11.3 Amgen
        11.3.1 Amgen Company Details
        11.3.2 Amgen Business Overview
        11.3.3 Amgen Personalized Medicine Introduction
        11.3.4 Amgen Revenue in Personalized Medicine Business (2016-2021)
        11.3.5 Amgen Recent Development
    11.4 Astellas Pharma
        11.4.1 Astellas Pharma Company Details
        11.4.2 Astellas Pharma Business Overview
        11.4.3 Astellas Pharma Personalized Medicine Introduction
        11.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2016-2021)
        11.4.5 Astellas Pharma Recent Development
    11.5 Astrazeneca
        11.5.1 Astrazeneca Company Details
        11.5.2 Astrazeneca Business Overview
        11.5.3 Astrazeneca Personalized Medicine Introduction
        11.5.4 Astrazeneca Revenue in Personalized Medicine Business (2016-2021)
        11.5.5 Astrazeneca Recent Development
    11.6 Bayer AG
        11.6.1 Bayer AG Company Details
        11.6.2 Bayer AG Business Overview
        11.6.3 Bayer AG Personalized Medicine Introduction
        11.6.4 Bayer AG Revenue in Personalized Medicine Business (2016-2021)
        11.6.5 Bayer AG Recent Development
    11.7 Celgene Corporation
        11.7.1 Celgene Corporation Company Details
        11.7.2 Celgene Corporation Business Overview
        11.7.3 Celgene Corporation Personalized Medicine Introduction
        11.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2016-2021)
        11.7.5 Celgene Corporation Recent Development
    11.8 Glaxosmithkline Plc
        11.8.1 Glaxosmithkline Plc Company Details
        11.8.2 Glaxosmithkline Plc Business Overview
        11.8.3 Glaxosmithkline Plc Personalized Medicine Introduction
        11.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2016-2021)
        11.8.5 Glaxosmithkline Plc Recent Development
    11.9 Illumina
        11.9.1 Illumina Company Details
        11.9.2 Illumina Business Overview
        11.9.3 Illumina Personalized Medicine Introduction
        11.9.4 Illumina Revenue in Personalized Medicine Business (2016-2021)
        11.9.5 Illumina Recent Development
    11.10 Johnson & Johnson
        11.10.1 Johnson & Johnson Company Details
        11.10.2 Johnson & Johnson Business Overview
        11.10.3 Johnson & Johnson Personalized Medicine Introduction
        11.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2016-2021)
        11.10.5 Johnson & Johnson Recent Development
    11.11 Laboratory Corporation
        11.11.1 Laboratory Corporation Company Details
        11.11.2 Laboratory Corporation Business Overview
        11.11.3 Laboratory Corporation Personalized Medicine Introduction
        11.11.4 Laboratory Corporation Revenue in Personalized Medicine Business (2016-2021)
        11.11.5 Laboratory Corporation Recent Development
    11.12 Merck
        11.12.1 Merck Company Details
        11.12.2 Merck Business Overview
        11.12.3 Merck Personalized Medicine Introduction
        11.12.4 Merck Revenue in Personalized Medicine Business (2016-2021)
        11.12.5 Merck Recent Development
    11.13 Novartis AG
        11.13.1 Novartis AG Company Details
        11.13.2 Novartis AG Business Overview
        11.13.3 Novartis AG Personalized Medicine Introduction
        11.13.4 Novartis AG Revenue in Personalized Medicine Business (2016-2021)
        11.13.5 Novartis AG Recent Development
    11.14 Roche Holding AG
        11.14.1 Roche Holding AG Company Details
        11.14.2 Roche Holding AG Business Overview
        11.14.3 Roche Holding AG Personalized Medicine Introduction
        11.14.4 Roche Holding AG Revenue in Personalized Medicine Business (2016-2021)
        11.14.5 Roche Holding AG Recent Development
    11.15 Siemens AG
        11.15.1 Siemens AG Company Details
        11.15.2 Siemens AG Business Overview
        11.15.3 Siemens AG Personalized Medicine Introduction
        11.15.4 Siemens AG Revenue in Personalized Medicine Business (2016-2021)
        11.15.5 Siemens AG Recent Development
    11.16 Takeda Pharmaceutical Company Limited
        11.16.1 Takeda Pharmaceutical Company Limited Company Details
        11.16.2 Takeda Pharmaceutical Company Limited Business Overview
        11.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Introduction
        11.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2016-2021)
        11.16.5 Takeda Pharmaceutical Company Limited Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Personalized Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Personalized Medicine Diagnostics
    Table 3. Key Players of Personalized Medical Care
    Table 4. Key Players of Personalized Medicine Therapeutics
    Table 5. Key Players of Personalized Nutrition and Wellness
    Table 6. Global Personalized Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Personalized Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Personalized Medicine Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Personalized Medicine Market Share by Regions (2016-2021)
    Table 10. Global Personalized Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Personalized Medicine Market Share by Regions (2022-2027)
    Table 12. Personalized Medicine Market Trends
    Table 13. Personalized Medicine Market Drivers
    Table 14. Personalized Medicine Market Challenges
    Table 15. Personalized Medicine Market Restraints
    Table 16. Global Personalized Medicine Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Personalized Medicine Market Share by Players (2016-2021)
    Table 18. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicine as of 2020)
    Table 19. Ranking of Global Top Personalized Medicine Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Personalized Medicine Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Personalized Medicine Product Solution and Service
    Table 23. Date of Enter into Personalized Medicine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Personalized Medicine Revenue Market Share by Type (2016-2021)
    Table 27. Global Personalized Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Personalized Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Personalized Medicine Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Personalized Medicine Revenue Market Share by Application (2016-2021)
    Table 31. Global Personalized Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Personalized Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Personalized Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Personalized Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Personalized Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Personalized Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Personalized Medicine Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Personalized Medicine Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Personalized Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Personalized Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Personalized Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Personalized Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Abbott Laboratories Company Details
    Table 64. Abbott Laboratories Business Overview
    Table 65. Abbott Laboratories Personalized Medicine Product
    Table 66. Abbott Laboratories Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 67. Abbott Laboratories Recent Development
    Table 68. Agilent Technologies Company Details
    Table 69. Agilent Technologies Business Overview
    Table 70. Agilent Technologies Personalized Medicine Product
    Table 71. Agilent Technologies Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 72. Agilent Technologies Recent Development
    Table 73. Amgen Company Details
    Table 74. Amgen Business Overview
    Table 75. Amgen Personalized Medicine Product
    Table 76. Amgen Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 77. Amgen Recent Development
    Table 78. Astellas Pharma Company Details
    Table 79. Astellas Pharma Business Overview
    Table 80. Astellas Pharma Personalized Medicine Product
    Table 81. Astellas Pharma Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 82. Astellas Pharma Recent Development
    Table 83. Astrazeneca Company Details
    Table 84. Astrazeneca Business Overview
    Table 85. Astrazeneca Personalized Medicine Product
    Table 86. Astrazeneca Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 87. Astrazeneca Recent Development
    Table 88. Bayer AG Company Details
    Table 89. Bayer AG Business Overview
    Table 90. Bayer AG Personalized Medicine Product
    Table 91. Bayer AG Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 92. Bayer AG Recent Development
    Table 93. Celgene Corporation Company Details
    Table 94. Celgene Corporation Business Overview
    Table 95. Celgene Corporation Personalized Medicine Product
    Table 96. Celgene Corporation Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 97. Celgene Corporation Recent Development
    Table 98. Glaxosmithkline Plc Company Details
    Table 99. Glaxosmithkline Plc Business Overview
    Table 100. Glaxosmithkline Plc Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 101. Glaxosmithkline Plc Recent Development
    Table 102. Illumina Company Details
    Table 103. Illumina Business Overview
    Table 104. Illumina Personalized Medicine Product
    Table 105. Illumina Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 106. Illumina Recent Development
    Table 107. Johnson & Johnson Company Details
    Table 108. Johnson & Johnson Business Overview
    Table 109. Johnson & Johnson Personalized Medicine Product
    Table 110. Johnson & Johnson Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 111. Johnson & Johnson Recent Development
    Table 112. Laboratory Corporation Company Details
    Table 113. Laboratory Corporation Business Overview
    Table 114. Laboratory Corporation Personalized Medicine Product
    Table 115. Laboratory Corporation Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 116. Laboratory Corporation Recent Development
    Table 117. Merck Company Details
    Table 118. Merck Business Overview
    Table 119. Merck Personalized Medicine Product
    Table 120. Merck Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 121. Merck Recent Development
    Table 122. Novartis AG Company Details
    Table 123. Novartis AG Business Overview
    Table 124. Novartis AG Personalized Medicine Product
    Table 125. Novartis AG Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 126. Novartis AG Recent Development
    Table 127. Roche Holding AG Company Details
    Table 128. Roche Holding AG Business Overview
    Table 129. Roche Holding AG Personalized Medicine Product
    Table 130. Roche Holding AG Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 131. Roche Holding AG Recent Development
    Table 132. Siemens AG Company Details
    Table 133. Siemens AG Business Overview
    Table 134. Siemens AG Personalized Medicine Product
    Table 135. Siemens AG Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 136. Siemens AG Recent Development
    Table 137. Takeda Pharmaceutical Company Limited Company Details
    Table 138. Takeda Pharmaceutical Company Limited Business Overview
    Table 139. Takeda Pharmaceutical Company Limited Personalized Medicine Product
    Table 140. Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
    Table 141. Takeda Pharmaceutical Company Limited Recent Development
    Table 142. Research Programs/Design for This Report
    Table 143. Key Data Information from Secondary Sources
    Table 144. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Personalized Medicine Market Share by Type: 2020 VS 2027
    Figure 2. Personalized Medicine Diagnostics Features
    Figure 3. Personalized Medical Care Features
    Figure 4. Personalized Medicine Therapeutics Features
    Figure 5. Personalized Nutrition and Wellness Features
    Figure 6. Global Personalized Medicine Market Share by Application: 2020 VS 2027
    Figure 7. Oncology Case Studies
    Figure 8. Central Nervous System (CNS) Case Studies
    Figure 9. Immunology Case Studies
    Figure 10. Respiratory Case Studies
    Figure 11. Other Applications Case Studies
    Figure 12. Personalized Medicine Report Years Considered
    Figure 13. Global Personalized Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Personalized Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Personalized Medicine Market Share by Regions: 2020 VS 2027
    Figure 16. Global Personalized Medicine Market Share by Regions (2022-2027)
    Figure 17. Global Personalized Medicine Market Share by Players in 2020
    Figure 18. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicine as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Personalized Medicine Revenue in 2020
    Figure 20. Global Personalized Medicine Revenue Market Share by Type (2016-2021)
    Figure 21. Global Personalized Medicine Revenue Market Share by Type (2022-2027)
    Figure 22. North America Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Personalized Medicine Market Share by Type (2016-2027)
    Figure 24. North America Personalized Medicine Market Share by Application (2016-2027)
    Figure 25. North America Personalized Medicine Market Share by Country (2016-2027)
    Figure 26. United States Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Personalized Medicine Market Share by Type (2016-2027)
    Figure 30. Europe Personalized Medicine Market Share by Application (2016-2027)
    Figure 31. Europe Personalized Medicine Market Share by Country (2016-2027)
    Figure 32. Germany Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Personalized Medicine Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Personalized Medicine Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Personalized Medicine Market Share by Region (2016-2027)
    Figure 42. China Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Personalized Medicine Market Share by Type (2016-2027)
    Figure 50. Latin America Personalized Medicine Market Share by Application (2016-2027)
    Figure 51. Latin America Personalized Medicine Market Share by Country (2016-2027)
    Figure 52. Mexico Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Personalized Medicine Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Personalized Medicine Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Personalized Medicine Market Share by Country (2016-2027)
    Figure 58. Turkey Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Abbott Laboratories Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 62. Agilent Technologies Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 63. Amgen Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 64. Astellas Pharma Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 65. Astrazeneca Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 66. Bayer AG Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 67. Celgene Corporation Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 68. Glaxosmithkline Plc Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 69. Illumina Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 70. Johnson & Johnson Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 71. Laboratory Corporation Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 72. Merck Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 73. Novartis AG Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 74. Roche Holding AG Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 75. Siemens AG Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 76. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Personalized Medicine Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Agilent Technologies
Amgen
Astellas Pharma
Astrazeneca
Bayer AG
Celgene Corporation
Glaxosmithkline Plc
Illumina
Johnson & Johnson
Laboratory Corporation
Merck
Novartis AG
Roche Holding AG
Siemens AG
Takeda Pharmaceutical Company Limited
Frequently Asked Questions
Personalized Medicine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Personalized Medicine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Personalized Medicine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports